WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

Weight-loss jabs linked to hundreds of life-threatening illness cases and 10 deaths

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK’s medicines regulator reveal

Raccontata daindependent.co.uktheguardian.combbc.comtechnologyreview.comtelegraph.co.uk

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
independent.co.ukStai leggendo1 anni fa

Weight-loss jabs linked to hundreds of life-threatening illness cases and 10 deaths

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK’s medicines…

originale
bbc.com1 anni fa

Weight loss jabs study begins after reports of pancreas issues

There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.

Leggi questa versione → originale
telegraph.co.uk1 anni fa

Weight-loss jabs linked to pancreas problems after 10 deaths

Cases not confirmed as directly caused by medicines, but health officials launching new study into side effects

Leggi questa versione → originale
theguardian.com1 anni fa

Hundreds of weight loss and diabetes jab users report pancreas problems

UK health officials launch study into side-effects of weight loss drugs after increased reports of acute pancreatitis

Leggi questa versione → originale
technologyreview.com1 anni fa

We’re learning more about what weight-loss drugs do to the body

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 26 giugno 2025·independent.co.uk

    ‘I was diagnosed with deadly condition after taking weight-loss jab offered on NHS’

    Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with pancreatitis and told to stop taking the weight-loss jab

  2. giovedì 26 giugno 2025·independent.co.uk

    Weight-loss jabs linked to hundreds of life-threatening illness cases and 10 deaths

    Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking…

  3. giovedì 26 giugno 2025·theguardian.com

    Hundreds of weight loss and diabetes jab users report pancreas problems

    UK health officials launch study into side-effects of weight loss drugs after increased reports of acute pancreatitis

  4. giovedì 26 giugno 2025·bbc.com

    Weight loss jabs study begins after reports of pancreas issues

    There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.

  5. giovedì 26 giugno 2025·technologyreview.com

    We’re learning more about what weight-loss drugs do to the body

    GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users.

  6. giovedì 26 giugno 2025·telegraph.co.uk

    Weight-loss jabs linked to pancreas problems after 10 deaths

    Cases not confirmed as directly caused by medicines, but health officials launching new study into side effects